817641-86-4

Basic information

• Product Name: 1-Tert-Butyl-3-Cyclobutyl-1H-pyrazol-5-amine
• Synonyms: 1-Tert-Butyl-3-Cyclobutyl-1H-pyrazol-5-amine;1-Tert-Butyl-3-Cyclobutyl-1H-Pyrazol-5-Amine(WX609261)
• CAS NO: 817641-86-4
• Molecular Formula: C₁₁H₁₉N₃
• Molecular Weight: 193.28866
• Mol File: 817641-86-4.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 331.669 °C at 760 mmHg
• Flash Point: 154.388 °C
• Appearance: /
• Density: 1.153 g/cm³
• CAS DataBase Reference: 1-Tert-Butyl-3-Cyclobutyl-1H-pyrazol-5-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Tert-Butyl-3-Cyclobutyl-1H-pyrazol-5-amine(817641-86-4)
• EPA Substance Registry System: 1-Tert-Butyl-3-Cyclobutyl-1H-pyrazol-5-amine(817641-86-4)

Safety Data

• Hazardous Substances Data: 817641-86-4(Hazardous Substances Data)

Usage

General Description

1-Tert-Butyl-3-Cyclobutyl-1H-pyrazol-5-amine is a chemical compound with the molecular formula C11H19N3. It is a pyrazole derivative with a tert-butyl group and a cyclobutyl group attached to the nitrogen atom. 1-Tert-Butyl-3-Cyclobutyl-1H-pyrazol-5-amine has potential applications in pharmaceutical and agrochemical industries due to its unique structure and biological activities. It can be used as a building block for the synthesis of various organic compounds and may also have properties that make it suitable for use as a pharmacological or pesticide agent. However, further research and testing are needed to fully understand and utilize the potential of this chemical.

Upstream product

• 7400-27-3 tertbutylhydrazine hydrochloride 
• 118431-89-3 β-Cyclobutyl-β-oxopropionitrile 
• 14924-53-9 ethyl cyclobutylcarboxylate 

Downstream Products

• 817641-87-5 1-tert-butyl-3-cyclobutyl-4-methyl-1,7-dihydro-pyrazolo[3,4-b]pyridin-6-one 

Relevant articles and documents

N-SULFONYLATED PYRAZOLO[3,4-B]PYRIDIN-6-CARBOXAMIDES AND METHOD OF USE

The present invention provides for compounds of formula (I) wherein R1, R2, R3, R4, R5, and R6 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions mediated and modulated by CFTR, including cystic fibrosis, Sj?gren's syndrome, pancreatic insufficiency, chronic obstructive lung disease, and chronic obstructive airway disease. Also provided are pharmaceutical compositions comprised of one or more compounds of formula (I).

PYRAZOLO`3,4-B!PYRIDIN-6-ONES AS GSK-3 INHIBITORS

The invention provides compounds of formula (I), the stereoisomers and prodrugs thereof, and the pharmaceutically acceptable salts of the compounds, stereoisomers, and prodrugs, wherein R1, R2, and R3 are as defined herein; pharmaceutical compositions thereof; and use thereof in the treatment of, inter alia, conditions, diseases, and symptoms such as diabetes, dementia, Alzheimer's Disease, stroke, schizophrenia, depression, hair loss, and cancer.